Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
38 42 Search
2025
Identification and functional regulation of three alternative splicing isoforms of the Ythdc2 gene in Miichthys miiuy
Developmental & Comparative Immunology
2025
m6A-driven transcriptomic rewiring in tumor immune surveillance
Journal for ImmunoTherapy of Cancer
2025
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma
BMC Cancer
2025
YTHDC2 manipulates anti-tumoral macrophage polarization and predicts favorable outcomes in triple negative breast cancer
npj Precision Oncology
2024
Role of m6A modifications in immune evasion and immunotherapy
Medical Oncology
2024
Exploring the impact of circRNAs on cancer glycolysis: Insights into tumor progression and therapeutic strategies
Non-coding RNA Research
2024
The biological function of the N6-Methyladenosine reader YTHDC2 and its role in diseases
Journal of Translational Medicine
2024
YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling
Applied Biochemistry and Biotechnology
2024
The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Clinical and Translational Medicine
2024
Dynamic m6A profiles reveal the role of YTHDC2‐TLR2 signaling axis in Talaromyces marneffei infection
Journal of Medical Virology
2024
Role of N6‐methyladenosine RNA modification in cancer
MedComm
2024
RNA modification in normal hematopoiesis and hematologic malignancies
MedComm
2024
N6-methyladenosine RNA modification in head and neck squamous cell carcinoma (HNSCC): current status and future insights
Medical Oncology
2024
METTL3 knockdown suppresses RA-FLS activation through m6A-YTHDC2-mediated regulation of AMIGO2
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
2023
Overexpression of YTHDC2 contributes to the progression of prostate cancer and predicts poor outcomes in patients with prostate cancer
Journal of Biochemical and Molecular Toxicology
2023
Understanding the Epitranscriptome for Avant-Garde Brain Tumour Diagnostics
Cancers
2023
Cancer Treatment and Research
2023
A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits
Discover Oncology
2023
m 6 A RNA methylation regulators predict prognosis and indicate characteristics of tumour microenvironment infiltration in acute myeloid leukaemia
Epigenetics
2023
Identification of a ferroptosis-related gene signature predicting recurrence in stage II/III colorectal cancer based on machine learning algorithms
Frontiers in Pharmacology
2022
Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
Journal of Clinical Laboratory Analysis
2022
RNA and RNA Derivatives: Light and Dark Sides in Cancer Immunotherapy
Antioxidants & Redox Signaling
2022
The m6A RNA Modification Quantity and the Prognostic Effect of Reader YTHDC2 in Colorectal Cancer
Clinical Medicine Insights: Oncology
2022
Regulation of epigenetic modifications in the head and neck tumour microenvironment
Frontiers in Immunology
2022
N6‐methyladenosine RNA methylation: A novel regulator of the development and function of immune cells
Journal of Cellular Physiology
2022
The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies
Cancers
2022
Development and Validation of a Ferroptosis-Related lncRNAs Prognosis Model in Oral Squamous Cell Carcinoma
Frontiers in Genetics
2022
M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer
Journal of Cancer Research and Clinical Oncology
2022
Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer
Bioengineered
2022
The Potential Role of m6A in the Regulation of TBI-Induced BGA Dysfunction
Antioxidants
2021
Targeting SLC3A2 subunit of system XC− is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma
Free Radical Biology and Medicine
2021
N6-Methyladenosine RNA Modification: An Emerging Immunotherapeutic Approach to Turning Up Cold Tumors
Frontiers in Cell and Developmental Biology
2021
The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review
Frontiers in Cell and Developmental Biology
2021
Roles of Major RNA Adenosine Modifications in Head and Neck Squamous Cell Carcinoma
Frontiers in Pharmacology
2021
N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
Frontiers in Immunology
2021
Decoding m6A mRNA methylation by reader proteins in cancer
Cancer Letters
2021
Roles of RNA Methylation on Tumor Immunity and Clinical Implications
Frontiers in Immunology
2021
Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors
Frontiers in Cell and Developmental Biology
Additional cited-by details will be shown when available from Crossref